GUGGENHEIM CAPITAL LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 139 filers reported holding ARRAY BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 3.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$5,341,000
+28.4%
115,289
-32.4%
0.04%
+26.5%
Q1 2019$4,160,000
+43.9%
170,643
-15.9%
0.03%
+41.7%
Q4 2018$2,891,000
-17.0%
202,847
-11.5%
0.02%
+4.3%
Q3 2018$3,482,000
+0.6%
229,107
+11.0%
0.02%0.0%
Q2 2018$3,462,000
+2.5%
206,364
-0.3%
0.02%
+187.5%
Q1 2018$3,377,000
+5.5%
206,918
-17.2%
0.01%0.0%
Q4 2017$3,200,000
-12.3%
250,014
-15.7%
0.01%
-11.1%
Q3 2017$3,649,000
+34.6%
296,622
-8.4%
0.01%
+28.6%
Q2 2017$2,712,000
+18.8%
323,966
+26.8%
0.01%
+16.7%
Q1 2017$2,283,000
-3.1%
255,441
-4.7%
0.01%
-14.3%
Q4 2016$2,357,000
+4521.6%
268,178
+2099.1%
0.01%
Q4 2015$51,000
-99.0%
12,195
-98.3%
0.00%
-100.0%
Q2 2015$5,033,000
+241.7%
698,115
+249.2%
0.01%
+300.0%
Q1 2015$1,473,000
+1890.5%
199,904
+1186.2%
0.00%
Q4 2014$74,000
+4.2%
15,542
-22.5%
0.00%
Q3 2014$71,000
-97.1%
20,063
-95.8%
0.00%
-100.0%
Q4 2013$2,418,000
-9.3%
482,613
+12.6%
0.01%
-30.0%
Q3 2013$2,666,000428,5700.01%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q4 2013
NameSharesValueWeighting ↓
Redmile Group, LLC 17,850,650$75,330,0005.64%
BVF INC/IL 6,682,711$28,201,0004.81%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 8,729,361$36,838,0001.49%
First Light Asset Management, LLC 530,391$2,238,0000.94%
KOPP INVESTMENT ADVISORS LLC 376,477$1,589,0000.78%
Sarissa Capital Management LP 700,000$2,954,0000.57%
Orbimed Advisors 10,689,000$45,108,0000.41%
Bedell Frazier Investment Counselling, LLC 178,971$755,0000.37%
PINNACLE ASSOCIATES LTD 3,453,487$14,574,0000.31%
Artal Group S.A. 3,710,000$15,656,0000.29%
View complete list of ARRAY BIOPHARMA INC shareholders